XERIS PHARMACEUTICALS INC's ticker is XERS and the CUSIP is 98422L107. A total of 72 filers reported holding XERIS PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 0.40 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $65,000 | +170.8% | 26,532 | +350.4% | 0.00% | – |
| Q2 2021 | $24,000 | -97.5% | 5,891 | -97.3% | 0.00% | – |
| Q1 2021 | $978,000 | +1557.6% | 216,831 | +1701.2% | 0.00% | – |
| Q4 2020 | $59,000 | +22.9% | 12,038 | +49.0% | 0.00% | – |
| Q3 2020 | $48,000 | +14.3% | 8,079 | -49.3% | 0.00% | – |
| Q2 2020 | $42,000 | -27.6% | 15,922 | -46.6% | 0.00% | – |
| Q1 2020 | $58,000 | -81.1% | 29,844 | -31.6% | 0.00% | – |
| Q4 2019 | $307,000 | +10.8% | 43,613 | +54.9% | 0.00% | – |
| Q3 2019 | $277,000 | +72.0% | 28,152 | +99.6% | 0.00% | – |
| Q2 2019 | $161,000 | +71.3% | 14,102 | +50.1% | 0.00% | – |
| Q1 2019 | $94,000 | -41.2% | 9,396 | 0.0% | 0.00% | – |
| Q4 2018 | $160,000 | +290.2% | 9,396 | +304.3% | 0.00% | – |
| Q3 2018 | $41,000 | +355.6% | 2,324 | +398.7% | 0.00% | – |
| Q2 2018 | $9,000 | – | 466 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sessa Capital IM, L.P. | 4,172,459 | $20,528,000 | 1.31% |
| DELTEC ASSET MANAGEMENT LLC | 693,870 | $3,414,000 | 0.52% |
| Alpine Global Management, LLC | 350,000 | $1,722,000 | 0.35% |
| Redmile Group, LLC | 2,397,441 | $11,795,000 | 0.14% |
| Kamunting Street Capital Management, L.P. | 43,833 | $216,000 | 0.11% |
| IHT Wealth Management, LLC | 250,798 | $1,234,000 | 0.10% |
| SEARLE & CO. | 34,000 | $167,000 | 0.08% |
| GPS Wealth Strategies Group, LLC | 46,025 | $226,000 | 0.08% |
| ArrowMark Colorado Holdings LLC | 1,981,909 | $9,751,000 | 0.08% |
| Gladstone Institutional Advisory LLC | 51,500 | $253 | 0.05% |